Orphan Drug Trial Sponsors ‘Playing Catch-Up’ With Regulators – But Automation Can Help

Clinical trial sponsors in the rare disease space face “big safety demands” from regulators, which can be challenging for those with limited resources. A CRO founder makes the case for “embedding automation” into the clinical trial process to keep pace with regulatory requirements.